Trifluoroacetic acid → HCID 117667718, compound
Reaction equation
C([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([C:14]2[CH:15]=[N:16][CH:17]=[C:18]([C:22]3[CH:23]=[N:24][C:25]4[N:26]([C:32](=[O:34])[NH2:33])[CH2:27][CH2:28][CH2:29][C:30]=4[CH:31]=3)[C:19]=2[C:20]#[N:21])[CH2:10][CH2:9]1)=O)(C)(C)C.F[C:36](F)(F)C(O)=O>C(Cl)Cl>[C:6]([N:8]1[CH2:9][CH2:10][CH:11]([C:14]2[CH:15]=[N:16][CH:17]=[C:18]([C:22]3[CH:31]=[C:30]4[C:25](=[N:24][CH:23]=3)[N:26]([C:32]([NH2:33])=[O:34])[CH2:27][CH2:28][CH2:29]4)[C:19]=2[C:20]#[N:21])[CH2:12][CH2:13]1)(=[O:5])[CH3:36]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
The crude 5-(8-carbamoyl-5,6,7,8-tetrahydro-[1,8]naphthyridin-3-yl)-4-cyano-3′,4′,5′,6′-tetrahydro-2′H-[3,4′]bipyridinyl-1′-carboxylic acid tert-butyl ester (0.22 mmol) is dissolved in DCM (2.0 mL) and trifluoroacetic acid (0.5 mL) is added. The mixture is stirred for 16 hrs and all the solvent is removed in vacuo. The residue is dissolved in MeOH and is passed through StratoSpheres SPE PL-HCO3 cartridge. The solution is concentrated to give the crude 6-(4-cyano-1′,2′,3′,4′,5′,6′-hexahydro-[3,4]bipyridinyl-5-yl)-3,4-dihydro-2H-[1,8]naphthyridine-1-carboxylic acid amide which is used without purification.
Workup
- customall the solvent is removed in vacuo
- dissolutionThe residue is dissolved in MeOH
- concentrationThe solution is concentrated
Sources & evidence
- ORD record
- ord-21b0329aaac94acaa2e47404b5c2c3e1
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09181272B2
Reaction notes
Loading…